Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Short term Debt (2020 - 2025)

Historic Short term Debt for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $32.6 million.

  • MDxHealth's Short term Debt rose 2576.45% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year increase of 2576.45%. This contributed to the annual value of $26.4 million for FY2024, which is 81229.71% up from last year.
  • MDxHealth's Short term Debt amounted to $32.6 million in Q3 2025, which was up 2576.45% from $27.7 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Short term Debt ranged from a high of $32.6 million in Q3 2025 and a low of $412000.0 during Q2 2022
  • Over the past 5 years, MDxHealth's median Short term Debt value was $14.3 million (recorded in 2021), while the average stood at $14.7 million.
  • Its Short term Debt has fluctuated over the past 5 years, first tumbled by 4760.19% in 2022, then surged by 575169.9% in 2023.
  • Over the past 5 years, MDxHealth's Short term Debt (Quarter) stood at $4.4 million in 2021, then tumbled by 47.6% to $2.3 million in 2022, then rose by 24.41% to $2.9 million in 2023, then skyrocketed by 812.3% to $26.4 million in 2024, then rose by 23.33% to $32.6 million in 2025.
  • Its Short term Debt was $32.6 million in Q3 2025, compared to $27.7 million in Q2 2025 and $27.6 million in Q1 2025.